Also trades as: ELLXF (OTC) · $vol 0M
EXL.AX ASX
Elixinol Wellness Limited
1W: -12.5%
1M: -12.5%
3M: +16.7%
YTD: -30.0%
1Y: -58.8%
A$0.01 ($0.01)
+0.00 (+14.29%)
Weekly Expected Move ±18.9%
A$0
A$0
A$0
A$0
A$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$16M
+3.6% ▲
5Y CAGR: +0.6%
Gross Profit
$752K
-86.0% ▼
Operating Income
-$5M
-43.5% ▼
Net Income
-$6M
-219.4% ▼
EPS (Diluted)
$-0.02
-93.7% ▼
EBITDA
-$4M
-2.4% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $9M | $7M | $8M | $15M | $16M |
| YoY Growth | -37.8% | -24.4% | +17.2% | +80.9% | +3.6% |
| Cost of Revenue | $16M | $10M | $10M | $10M | $15M |
| Gross Profit | -$6M | -$3M | -$2M | $5M | $752K |
| Gross Margin | -67.0% | -46.3% | -21.8% | 35.8% | 4.9% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $17M | $7M | $8M | $8M | $5M |
| Operating Expenses | $9M | $7M | $10M | $9M | $6M |
| Operating Income | -$16M | -$10M | -$6M | -$3M | -$5M |
| Operating Margin | -167.2% | -141.8% | -77.8% | -23.2% | -32.1% |
| Interest Expense | $92K | $71K | $101K | $212K | $488K |
| Income Before Tax | -$17M | -$11M | -$8M | -$5M | -$6M |
| Tax Expense | -$65K | $2K | $3K | -$4M | -$535K |
| Net Income | -$17M | -$11M | -$8M | -$2M | -$6M |
| Net Margin | -182.3% | -149.8% | -90.8% | -11.5% | -35.5% |
| EPS (Diluted) | $-0.04 | $-0.03 | $-0.01 | $-0.01 | $-0.02 |
| EBITDA | -$16M | -$9M | -$7M | -$4M | -$4M |
| Shares Outstanding | 405M | 406M | 609M | 155M | 256M |